Deals
Kirin Pushes Expansion of Wellness Business in $1.2 Billion Deal
- Brewer to make chemical, vitamins supplier a direct subsidiary
- Kirin targets 100 billion yen for wellness product revenue
People walk past a sign at the Kirin Holdings Co. headquarters in Tokyo.
Photographer: Kiyoshi Ota/Bloomberg
This article is for subscribers only.
Kirin Holdings Co. agreed to acquire most of the biochemicals business from its Kyowa Hakko Kirin Co. unit in a transaction valued at 128 billion yen ($1.2 billion) as it seeks to strengthen its budding consumer health-care segment.